4//SEC Filing
Quan Lucinda Y. 4
Accession 0001567619-22-002890
CIK 0001799448other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:07 PM ET
Size
8.0 KB
Accession
0001567619-22-002890
Insider Transaction Report
Form 4
Quan Lucinda Y.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-02-04+105,000→ 105,000 totalExercise: $3.06Exp: 2032-02-04→ Common Stock (105,000 underlying) - Award
Stock Option (Right to Buy)
2022-02-04+26,250→ 26,250 totalExercise: $3.06Exp: 2032-02-04→ Common Stock (26,250 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F2]100% of the shares subject to the Option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through such vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001824711
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:07 PM ET
- Size
- 8.0 KB